Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 3482 | Pages: 175 | September 2017 | Region: Global


The Global Competent Cells Market is worth USD1.3 billion in 2016 and estimated to grow at a CAGR of 10.3%, to reach USD2.12 billion by 2021. The global Competent Cells market is developing at an exceptionally quick pace.

Transformation is a manner of horizontal gene transfer by which some bacteria take up external genetic material (naked DNA) from the environment. The precondition for microorganisms to undergo transformation is its ability to take up open, extracellular genetic material. Such microorganisms are termed as competent cells.

Developments in molecular cloning research due to the advent of new technologies and the rising commercial demand for molecular cloned products and recombinant proteins are some the key force driving the growth of this market. However, growing market consolidation creating strong entry barriers and huge cost of competent cells kits are restricting the growth of this market.

The Global market for Competent Cells is segmented on the basis of type, application, end user and region. Based on type, the market is segmented into Chemically, Electrocompetent. Based on application, the market is segmented into Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, and Mutagenesis. The chemically competent cells segment is expected to dominate the market in 2016. Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. Based on end user, the market is segmented into Pharmaceutical Companies, Academia. Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. In 2016, the academic research institutes segment is likely to have for the largest share of the market.

Geographically, the Competent Cells market is fragmented into Asia-Pacific, North America, Europe, Latin America and Middle East Asia. North America is estimated to constitute the largest share in this market, while the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second largest shareholder for the market during the forecast period.

BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan),  Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.),  Bioline (U.K.), Zymo Research (U.S.),are the leaders in the global Competent Cells market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Chemically               

                                5.1.2 Electrocompetent

                                5.1.3  Y-o-Y Growth Analysis, By Type    

                                5.1.4  Market Attractiveness Analysis, By Type  

                                5.1.5  Market Share Analysis, ByType     

                5.2 Application                 

                                5.2.1 Cloning     

                                                5.2.1.1  Subcloning & Routine Cloning

                                                5.2.1.2 Phage Display Library Construction

                                                5.2.1.3 Toxic/Unstable Dna Cloning

                                                5.2.1.4 High-Throughput Cloning

                                5.2.2 Protein Expression              

                                5.2.3 Other Applications               

                                                5.2.3.1 Mutagenesis

                                                5.2.3.2 Large Plasmid Transformation

                                                5.2.3.4 Single-Stranded Dna Production

                                                5.2.3.5 Lentiviral Vector Production

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8  Market Attractiveness Analysis, By Application      

                                5.2.9  Market Share Analysis, By Application       

                5.3 End User                      

                                5.3.1 Pharmaceutical Companies              

                                5.3.2 Academia

                                5.3.3 Y-o-Y Growth Analysis, By EndUser              

                                5.3.4  Market Attractiveness Analysis, By EndUser           

                                5.3.5  Market Share Analysis, By EndUser             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Application

                                                6.1.3.4 By EndUser

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Application

                                                6.1.4.4 By EndUser

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Application

                                                6.1.5.4 By EndUser

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 BioDynamics Laboratory, Inc. (Japan)                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GCC Biotech (India)                 

                8.3 SMOBIO Technology (Taiwan)                            

                8.4 Thermo Fisher Scientific, Inc. (U.S)                   

                8.5 QIAGEN N.V. (Germany)                      

                8.6 OriGene Technologies (U.S.)                              

                8.7 Merck KGaA (Germany)                       

                8.8 Promega Corporation (U.S.)                

                8.9 Bioline (U.K.)                             

                8.10 Zymo Research (U.S.)                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Competent cells Market By Region, From 2016-2021 ( USD Million )
  2. Global Competent cells Market By Type, From 2016-2021 ( USD Million )
  3. Global Chemically Market By Region, From 2016-2021 ( USD Million )
  4. Global Electro Competent Market By Region, From 2016-2021 ( USD Million )
  5. Global Competent cells Market By Application, From 2016-2021 ( USD Million )
  6. Global SubCloning Market By Region, From 2016-2021 ( USD Million )
  7. Global Phage Display Library Production Market By Region, From 2016-2021 ( USD Million )
  8. Global Unstable DNA Cloning Market By Region, From 2016-2021 ( USD Million )
  9. Global High-Throughput Cloning Market By Region, From 2016-2021 ( USD Million )
  10. Global  Mutagenesis Market By Region, From 2016-2021 ( USD Million )
  11. Global Competent cells Market By End User, From 2016-2021 ( USD Million )
  12. Global Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Million )
  13. Global Academia Market By Region, From 2016-2021 ( USD Million )
  14. North America Competent cells Market By Type, From 2016-2021 ( USD Million )
  15. North America Chemically Market By Region, From 2016-2021 ( USD Million )
  16. North America Electro Competent Market By Region, From 2016-2021 ( USD Million )
  17. North America Competent cells Market By Application, From 2016-2021 ( USD Million )
  18. North America SubCloning Market By Region, From 2016-2021 ( USD Million )
  19. North America Phage Display Library Production Market By Region, From 2016-2021 ( USD Million )
  20. North America Unstable DNA Cloning Market By Region, From 2016-2021 ( USD Million )
  21. North America High-Throughput Cloning Market By Region, From 2016-2021 ( USD Million )
  22. North America  Mutagenesis Market By Region, From 2016-2021 ( USD Million )
  23. North America Competent cells Market By End User, From 2016-2021 ( USD Million )
  24. North America Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Million )
  25. North America Academia Market By Region, From 2016-2021 ( USD Million )
  26. United States Competent cells Market By Type, From 2016-2021 ( USD Million )
  27. United States Competent cells Market By Application, From 2016-2021 ( USD Million )
  28. United States Competent cells Market By End User, From 2016-2021 ( USD Million )
  29. Canada Competent cells Market By Type, From 2016-2021 ( USD Million )
  30. Canada Competent cells Market By Application, From 2016-2021 ( USD Million )
  31. Canada Competent cells Market By End User, From 2016-2021 ( USD Million )
  32. Europe Competent cells Market By Type, From 2016-2021 ( USD Million )
  33. Europe Chemically Market By Region, From 2016-2021 ( USD Million )
  34. Europe Electro Competent Market By Region, From 2016-2021 ( USD Million )
  35. Europe Competent cells Market By Application, From 2016-2021 ( USD Million )
  36. Europe SubCloning Market By Region, From 2016-2021 ( USD Million )
  37. Europe Phage Display Library Production Market By Region, From 2016-2021 ( USD Million )
  38. Europe Unstable DNA Cloning Market By Region, From 2016-2021 ( USD Million )
  39. Europe High-Throughput Cloning Market By Region, From 2016-2021 ( USD Million )
  40. Europe  Mutagenesis Market By Region, From 2016-2021 ( USD Million )
  41. Europe Competent cells Market By End User, From 2016-2021 ( USD Million )
  42. Europe Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Million )
  43. Europe Academia Market By Region, From 2016-2021 ( USD Million )
  44. U.K. Competent cells Market By Type, From 2016-2021 ( USD Million )
  45. U.K. Competent cells Market By Application, From 2016-2021 ( USD Million )
  46. U.K. Competent cells Market By End User, From 2016-2021 ( USD Million )
  47. Germany Competent cells Market By Type, From 2016-2021 ( USD Million )
  48. Germany Competent cells Market By Application, From 2016-2021 ( USD Million )
  49. Germany Competent cells Market By End User, From 2016-2021 ( USD Million )
  50. France Competent cells Market By Type, From 2016-2021 ( USD Million )
  51. France Competent cells Market By Application, From 2016-2021 ( USD Million )
  52. France Competent cells Market By End User, From 2016-2021 ( USD Million )
  53. Italy Competent cells Market By Type, From 2016-2021 ( USD Million )
  54. Italy Competent cells Market By Application, From 2016-2021 ( USD Million )
  55. Italy Competent cells Market By End User, From 2016-2021 ( USD Million )
  56. Spain Competent cells Market By Type, From 2016-2021 ( USD Million )
  57. Spain Competent cells Market By Application, From 2016-2021 ( USD Million )
  58. Spain Competent cells Market By End User, From 2016-2021 ( USD Million )
  59. Asia-Pacific Competent cells Market By Type, From 2016-2021 ( USD Million )
  60. Asia-Pacific Chemically Market By Region, From 2016-2021 ( USD Million )
  61. Asia-Pacific Electro Competent Market By Region, From 2016-2021 ( USD Million )
  62. Asia-Pacific Competent cells Market By Application, From 2016-2021 ( USD Million )
  63. Asia-Pacific SubCloning Market By Region, From 2016-2021 ( USD Million )
  64. Asia-Pacific Phage Display Library Production Market By Region, From 2016-2021 ( USD Million )
  65. Asia-Pacific Unstable DNA Cloning Market By Region, From 2016-2021 ( USD Million )
  66. Asia-Pacific High-Throughput Cloning Market By Region, From 2016-2021 ( USD Million )
  67. Asia-Pacific  Mutagenesis Market By Region, From 2016-2021 ( USD Million )
  68. Asia-Pacific Competent cells Market By End User, From 2016-2021 ( USD Million )
  69. Asia-Pacific Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Million )
  70. Asia-Pacific Academia Market By Region, From 2016-2021 ( USD Million )
  71. Japan Competent cells Market By Type, From 2016-2021 ( USD Million )
  72. Japan Competent cells Market By Application, From 2016-2021 ( USD Million )
  73. Japan Competent cells Market By End User, From 2016-2021 ( USD Million )
  74. China Competent cells Market By Type, From 2016-2021 ( USD Million )
  75. China Competent cells Market By Application, From 2016-2021 ( USD Million )
  76. China Competent cells Market By End User, From 2016-2021 ( USD Million )
  77. India Competent cells Market By Type, From 2016-2021 ( USD Million )
  78. India Competent cells Market By Application, From 2016-2021 ( USD Million )
  79. India Competent cells Market By End User, From 2016-2021 ( USD Million )
  80. Australia Competent cells Market By Type, From 2016-2021 ( USD Million )
  81. Australia Competent cells Market By Application, From 2016-2021 ( USD Million )
  82. Australia Competent cells Market By End User, From 2016-2021 ( USD Million )
  83. South Korea Competent cells Market By Type, From 2016-2021 ( USD Million )
  84. South Korea Competent cells Market By Application, From 2016-2021 ( USD Million )
  85. South Korea Competent cells Market By End User, From 2016-2021 ( USD Million )
  86. Latin America Competent cells Market By Type, From 2016-2021 ( USD Million )
  87. Latin America Chemically Market By Region, From 2016-2021 ( USD Million )
  88. Latin America Electro Competent Market By Region, From 2016-2021 ( USD Million )
  89. Latin America Competent cells Market By Application, From 2016-2021 ( USD Million )
  90. Latin America SubCloning Market By Region, From 2016-2021 ( USD Million )
  91. Latin America Phage Display Library Production Market By Region, From 2016-2021 ( USD Million )
  92. Latin America Unstable DNA Cloning Market By Region, From 2016-2021 ( USD Million )
  93. Latin America High-Throughput Cloning Market By Region, From 2016-2021 ( USD Million )
  94. Latin America  Mutagenesis Market By Region, From 2016-2021 ( USD Million )
  95. Latin America Competent cells Market By End User, From 2016-2021 ( USD Million )
  96. Latin America Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Million )
  97. Latin America Academia Market By Region, From 2016-2021 ( USD Million )
  98. Brazil Competent cells Market By Type, From 2016-2021 ( USD Million )
  99. Brazil Competent cells Market By Application, From 2016-2021 ( USD Million )
  100. Brazil Competent cells Market By End User, From 2016-2021 ( USD Million )
  101. Argentina Competent cells Market By Type, From 2016-2021 ( USD Million )
  102. Argentina Competent cells Market By Application, From 2016-2021 ( USD Million )
  103. Argentina Competent cells Market By End User, From 2016-2021 ( USD Million )
  104. Mexico Competent cells Market By Type, From 2016-2021 ( USD Million )
  105. Mexico Competent cells Market By Application, From 2016-2021 ( USD Million )
  106. Mexico Competent cells Market By End User, From 2016-2021 ( USD Million )
  107. Rest of Latin America Competent cells Market By Type, From 2016-2021 ( USD Million )
  108. Rest of Latin America Competent cells Market By Application, From 2016-2021 ( USD Million )
  109. Rest of Latin America Competent cells Market By End User, From 2016-2021 ( USD Million )
  110. Middle East & Africa Competent cells Market By Type, From 2016-2021 ( USD Million )
  111. Middle East & Africa Chemically Market By Region, From 2016-2021 ( USD Million )
  112. Middle East & Africa Electro Competent Market By Region, From 2016-2021 ( USD Million )
  113. Middle East & Africa Competent cells Market By Application, From 2016-2021 ( USD Million )
  114. Middle East & Africa SubCloning Market By Region, From 2016-2021 ( USD Million )
  115. Middle East & Africa Phage Display Library Production Market By Region, From 2016-2021 ( USD Million )
  116. Middle East & Africa Unstable DNA Cloning Market By Region, From 2016-2021 ( USD Million )
  117. Middle East & Africa High-Throughput Cloning Market By Region, From 2016-2021 ( USD Million )
  118. Middle East & Africa  Mutagenesis Market By Region, From 2016-2021 ( USD Million )
  119. Middle East & Africa Competent cells Market By End User, From 2016-2021 ( USD Million )
  120. Middle East & Africa Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Million )
  121. Middle East & Africa Academia Market By Region, From 2016-2021 ( USD Million )
  122. Middle East Competent cells Market By Type, From 2016-2021 ( USD Million )
  123. Middle East Competent cells Market By Application, From 2016-2021 ( USD Million )
  124. Middle East Competent cells Market By End User, From 2016-2021 ( USD Million )
  125. Africa Competent cells Market By Type, From 2016-2021 ( USD Million )
  126. Africa Competent cells Market By Application, From 2016-2021 ( USD Million )
  127. Africa Competent cells Market By End User, From 2016-2021 ( USD Million )
Middle East And Africa Preimplantation Genetic Testing Market By Procedure Type (Genetic Diagnosis, Genetic Screening), By Technology (NGS, PCR, FISH, CGH, SNP), By Products & Services (Reagents And Consumables, In...
Latin America Preimplantation Genetic Testing Market By Procedure Type (Genetic Diagnosis, Genetic Screening), By Technology (NGS, PCR, FISH, CGH, SNP), By Products & Services (Reagents And Consumables, Instruments...
Asia Pacific Preimplantation Genetic Testing Market By Procedure Type (Genetic Diagnosis, Genetic Screening), By Technology (NGS, PCR, FISH, CGH, SNP), By Products & Services (Reagents And Consumables, Instruments,...
Europe Preimplantation Genetic Testing Market By Procedure Type (Genetic Diagnosis, Genetic Screening), By Technology (NGS, PCR, FISH, CGH, SNP), By Products & Services (Reagents And Consumables, Instruments, Softw...
North America Preimplantation Genetic Testing Market By Procedure Type (Genetic Diagnosis, Genetic Screening), By Technology (NGS, PCR, FISH, CGH, SNP), By Products & Services (Reagents And Consumables, Instruments...
Preimplantation Genetic Testing Market By Procedure Type (Genetic Diagnosis, Genetic Screening), By Technology (NGS, PCR, FISH, CGH, SNP), By Products & Services (Reagents And Consumables, Instruments, Software And...
Middle East And Africa Cellular Health Screening Market By Type (Single Test Panels And Multi Test Panels), By Sample Type (Blood Samples And Other Samples), By Sample Collection Site (In-Office Sample Collection, A...
Latin America Cellular Health Screening Market By Type (Single Test Panels And Multi Test Panels), By Sample Type (Blood Samples And Other Samples), By Sample Collection Site (In-Office Sample Collection, At-Home Sa...
Asia Pacific Cellular Health Screening Market By Type (Single Test Panels And Multi Test Panels), By Sample Type (Blood Samples And Other Samples), By Sample Collection Site (In-Office Sample Collection, At-Home Sam...
Europe Cellular Health Screening Market By Type (Single Test Panels And Multi Test Panels), By Sample Type (Blood Samples And Other Samples), By Sample Collection Site (In-Office Sample Collection, At-Home Sample Co...
North America Cellular Health Screening Market By Type (Single Test Panels And Multi Test Panels), By Sample Type (Blood Samples And Other Samples), By Sample Collection Site (In-Office Sample Collection, At-Home Sa...
Cellular Health Screening Market By Type (Single Test Panels And Multi Test Panels), By Sample Type (Blood Samples And Other Samples), By Sample Collection Site (In-Office Sample Collection, At-Home Sample Collectio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.